Definium Therapeutics (DFTX) had the highest return in Q1 2020 by a mid-cap US stock, returning 900%.
| ASSET | QUARTER | % RETURN |
|---|---|---|
Definium Therapeutics (DFTX) | Q1 2020 | 900% |
Aura Minerals Inc Common Shares (AUGO) | Q1 2020 | 107.12% |
VNET Group Inc DRC (VNET) | Q1 2020 | 85.05% |
Acm Research (ACMR) | Q1 2020 | 58.09% |
Twist Bioscience (TWST) | Q1 2020 | 44.11% |
Kiniksa Pharmaceuticals (KNSA) | Q1 2020 | 39.33% |
Arcus Biosciences (RCUS) | Q1 2020 | 37.43% |
Arcutis Biotherapeutics (ARQT) | Q1 2020 | 29.23% |
Ringcentral (RNG) | Q1 2020 | 24.65% |
DocuSign (DOCU) | Q1 2020 | 24.34% |
Syndax Pharmaceuticals (SNDX) | Q1 2020 | 23.68% |
Zai Lab (ZLAB) | Q1 2020 | 23.31% |
Enphase Energy (ENPH) | Q1 2020 | 22.45% |
Qiagen (QGEN) | Q1 2020 | 21.32% |
iRhythm Technologies (IRTC) | Q1 2020 | 18.45% |
Palomar (PLMR) | Q1 2020 | 14.94% |
Enliven Therapeutics (ELVN) | Q1 2020 | 14.5% |
Masimo (MASI) | Q1 2020 | 12.03% |
Cytokinetics (CYTK) | Q1 2020 | 10.81% |
Plug Power (PLUG) | Q1 2020 | 10.28% |
TAL Education (TAL) | Q1 2020 | 10.06% |
GDS (GDS) | Q1 2020 | 9.87% |
Vipshop (VIPS) | Q1 2020 | 9.18% |
PLDT Inc ADR (PHI) | Q1 2020 | 8.39% |
ICU Medical (ICUI) | Q1 2020 | 7.78% |
Mid-cap stocks are treated as having a market cap between $2B and $10B.
